The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Harmon Cyrus since 2021.
This trader's CIK number is 1831410.
At the time of last reporting, Harmon Cyrus was the Officer of Olema Pharmaceuticals, Inc.. (stock ticker symbol OLMA).
Also see all insider trading activities at Olema Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | OLMA | 0 | $0 | 191,393 | $2,223,140 | 0 | $0 |
| 2023 | OLMA | 0 | $0 | 158,181 | $1,813,239 | 0 | $0 |
| 2021 | OLMA | 0 | $0 | 60,400 | $1,568,425 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-10 | OLMA | Sale | 8,256 | 9.37 | 77,358 |
| 2024-12-11 | OLMA | Sale | 8,137 | 9.03 | 73,436 |
| 2024-07-29 | OLMA | Sale | 4,066 | 15.58 | 63,348 |
| 2024-07-30 | OLMA | Sale | 934 | 15.55 | 14,523 |
| 2024-07-11 | OLMA | Sale | 5,000 | 12.26 | 61,300 |
| 2024-06-28 | OLMA | Sale | 20,000 | 10.77 | 215,400 |
| 2024-06-04 | OLMA | Sale | 5,000 | 12.33 | 61,650 |
| 2024-06-03 | OLMA | Sale | 5,000 | 10.93 | 54,650 |
| 2024-05-31 | OLMA | Sale | 15,000 | 9.41 | 141,150 |
| 2024-05-06 | OLMA | Sale | 5,000 | 10.92 | 54,600 |
| 2024-04-30 | OLMA | Sale | 15,000 | 9.51 | 142,650 |
| 2024-03-28 | OLMA | Sale | 20,000 | 10.97 | 219,400 |
| 2024-02-29 | OLMA | Sale | 25,000 | 12.71 | 317,625 |
| 2024-02-01 | OLMA | Sale | 5,000 | 15.56 | 77,800 |
| 2024-01-31 | OLMA | Sale | 25,000 | 12.23 | 305,750 |
| 2023-12-29 | OLMA | Sale | 25,000 | 13.70 | 342,500 |
| 2023-11-30 | OLMA | Sale | 25,000 | 12.57 | 314,250 |
| 2023-11-21 | OLMA | Sale | 4,192 | 14.86 | 62,293 |
| 2023-11-22 | OLMA | Sale | 3,989 | 13.90 | 55,447 |
| 2023-11-02 | OLMA | Sale | 5,000 | 15.64 | 78,200 |
| 2023-10-31 | OLMA | Sale | 25,000 | 12.05 | 301,250 |
| 2023-09-29 | OLMA | Sale | 25,000 | 12.41 | 310,250 |
| 2023-09-29 | OLMA | Sale | 25,000 | 12.41 | 310,250 |
| 2023-08-31 | OLMA | Sale | 15,000 | 9.36 | 140,400 |
| 2023-09-05 | OLMA | Sale | 10,000 | 11.62 | 116,199 |
| 2023-06-08 | OLMA | Sale | 10,000 | 6.30 | 63,000 |
| 2023-06-05 | OLMA | Sale | 5,000 | 6.04 | 30,225 |
| 2023-06-06 | OLMA | Sale | 5,000 | 6.29 | 31,475 |
| 2021-11-29 | OLMA | Sale | 400 | 24.76 | 9,904 |
| 2021-10-19 | OLMA | Sale | 12,000 | 28.02 | 336,300 |
| 2021-09-20 | OLMA | Sale | 12,000 | 26.30 | 315,600 |
| 2021-08-19 | OLMA | Sale | 12,000 | 24.97 | 299,640 |
| 2021-07-19 | OLMA | Sale | 7,877 | 24.83 | 195,585 |
| 2021-07-20 | OLMA | Sale | 4,123 | 25.63 | 105,672 |
| 2021-06-18 | OLMA | Sale | 12,000 | 25.48 | 305,724 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harmon Cyrus (Officer of Olema Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.